mAbxience | About us
mAbxience is a high growth international biotechnology company founded in Spain in 2009. We specialize in the research, development, manufacturing and global commercialization of monoclonal antibody biosimilars to treat and prevent diseases across different therapeutic areas.
Our organization is built on a solid B2B model which empowers us to commercialize our products around the world via a consolidated network of local partners – all leaders in their markets.
mAbxience relies on a multi-disciplinary, dynamic, young and enthusiastic team of more than 260 people supported by an experienced management team. The company belongs to the Spanish multinational Insud Pharma, a group committed to investing in all areas of business and which draws on 40 years of experience and more than 6,000 professionals across 40 countries around the world.